Home > Food & Beverages > Nutraceuticals > Omega 3 > Glutathione Market
Global Glutathione Market size was over USD 195 million in 2020 and is estimated to grow at over 7% CAGR up to 2027 owing to wide application of glutathione in numerous industries such as pharmaceutical, cosmetic, food and nutraceuticals. Growing adoption of glutathione in chemotherapy should promote market growth in the coming timeframe.
Glutathione is an important antioxidant in the human body, which helps combat free radicals, detoxify chemicals which are naturally created by human body, and also detoxifies drugs and pollutants present in the environment. Moreover, glutathione provides protection against the harmful effects of radiation and chemotherapy for cancer along with treatment for weakened immune systems or infertility. These benefits of the product should fuel the glutathione market share in the pharmaceutical and food industry worldwide.
The outbreak of the COVID-19 pandemic and lockdown imposed by governments to prevent the spread of COVID-19 has resulted in disrupted supply chains. Also, the spread of COVID-19 has disrupted worker productivity and has led to shortages of production in different industrial sectors. In addition, the consciousness among the consumers towards health, cleanliness and healthy habits are on rise.
Report Attribute | Details |
---|---|
Base Year: | 2020 |
Glutathione Market Size in 2020: | USD 316.56 Million |
Forecast Period: | 2021 to 2027 |
Forecast Period 2021 to 2027 CAGR: | 7.1% |
2027 Value Projection: | USD 197.13 Million |
Historical Data for: | 2016 to 2020 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 272 |
Segments covered: | Product |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Glutathione plays an important role in the boosting immune system and aids to fight against various pollutants present in the environment. This property supports the glutathione market demand in the COVID-19 pandemic as well and anticipated to grow over the coming years too.
The stringent regulations laid down by governing bodies of different regions on the manufacturing, labeling and product consumption are likely to restrain the glutathione market growth of to some extent during the forecast period. For instance, FDA communicated with the manufacturers of L-glutathione, to confirm that the ingredient is not proposed for use in sterile drugs, where the L-glutathione is only promoted in the U.S. for use in dietary supplements. However, manufacturer also advise their U.S. customers about the application of L-glutathione in sterile drugs, to sustain in the market.